May 26, 2020
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction
May 06, 2020
FDA Clears New Mechanical Thrombectomy Platform
Apr 23, 2020
China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market, Forecast to 2024 - Growing Consumption of Fast Food, Rising PCI Prevalence, Increasing STEMI Patients
Mar 05, 2020
Plaque Modification Devices Market to Reach US$ 2.1 Bn by 2027: TMR
Mar 04, 2020
Cardiac Biomarkers - An Essential Tool in the Diagnosis and Management of Cardiovascular Diseases: Infinium Global Research
Mar 03, 2020
Cardiac Biomarker Diagnostic Kits Market by Product Type, Disease Indication, Testing and Geography - Forecast to 2027
Feb 13, 2020
Bayer®Aspirin Asks: Do You Know Your "Hidden Risk" for a Heart Attack?
Feb 03, 2020
How to Reduce Your Risk for Another Heart Attack
Jan 13, 2020
Cardisio Demonstrates Unprecedented Accuracy in New Non-Invasive Coronary Artery Disease Detection
Nov 19, 2019
Faraday Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Trial of FDY-5301 for Treatment of Reperfusion Injury Following a STEMI Heart Attack
Oct 22, 2019
Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis
Sep 26, 2019
Aspirin Continues to be the Gold Standard Treatment for Millions of Americans Who Have Had a Cardiovascular Event
Sep 26, 2019
Boston Scientific Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY(TM) Bioabsorbable Polymer Stent
Sep 25, 2019
U.S. FDA Clears Abbott's High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks Faster and More Accurately
Sep 09, 2019
Recardio's Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin Now Enrolling and Recruiting in All Global Centers
Jul 24, 2019
The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period
Jul 22, 2019
Daily Aspirin Still Recommended for Millions of Americans Who Have Had a Heart Attack or Ischemic Stroke
Jul 09, 2019
Cardiac Biomarker Testing Market Size Soaring at 11.4% CAGR to Assess $18,232 Million by 2026
Jun 13, 2019
Cardiac Biomarkers Testing Market to Reach $18.23 Bn, Globally, by 2026 at 11.4% CAGR: Allied Market Research
May 14, 2019
The global mobile cardiac telemetry systems market is expected to reach US$ 1,546.4 Mn in 2027 from US$ 564.8 Mn in 2018